Scientists discover harder-to-detect version of Omicron in Australia

The discovery comes as Queensland prepares to finally reopen its border to the rest of Australia ahead of schedule next Monday, as more than 80% of the eligible population will be fully vaccinated

Covid-19, Australia Covid-19,
Photo: Bloomberg
Matthew Burgess | Bloomberg
2 min read Last Updated : Dec 08 2021 | 6:55 PM IST
Australia’s Queensland state has found a new omicron lineage in a traveler who arrived from South Africa, health authorities said Wednesday. 

The new lineage has about half the gene variations of the original and can’t be detected with typical screening, the state’s acting chief health officer Peter Aitken told reporters. It was found in a traveler who had arrived from South Africa and tested positive for the coronavirus on Saturday, he said. 

The new lineage has enough markers “to be able to classify it as omicron, but we don’t know enough about it as to what that means then as far as clinical severity, vaccine effectiveness,” Aitken said. “We now have omicron and omicron-like.”

The discovery comes as Queensland prepares to finally reopen its border to the rest of Australia ahead of schedule next Monday, as more than 80% of the eligible population will be fully vaccinated later this week.

The discovery may be a setback for scientists racing to understand the full impact of the omicron variant, including how virulent the strain is and whether vaccines are effective at reducing risk of severe disease. Although most genetic changes are innocuous as viruses mutate, some can make the mutant more adept at infecting cells, for example, or evading antibodies. 

The new lineage has about half, or 14, of the genome mutations of the conventional omicron variant and doesn’t have the s-gene dropout feature, making it harder to track through PCR testing, Aitken said. The discovery is “going to lead to improvements in people recognizing potential spread of omicron in all communities,” he said.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusAustraliaCoronavirus TestsCoronavirus Vaccine

Next Story